A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...
A simple urine test could accurately detect recurring kidney cancer in patients recovering from surgery for the disease, potentially sparing them from frequent follow-up scans, researchers suggest.The ...
NIMS urologists perform first robotic kidney transplant, showcasing innovation and excellence in public healthcare at no cost ...
The patient, hailing from Nalgonda, had undergone a living-related kidney transplant in 2017 but was struggling due to ...
Kidney disease and kidney failure is common amongst Texans. 76,126 Texans were living with end-stage renal disease in 2024, shared the American Kidney Fund. Also, ...
Novartis’ oral Fabhalta (iptacopan) has been approved by the US Food and Drug Administration (FDA) as the first treatment for ...
Crawling into bed to rest her painful left toe, Mel Gardener winced as she covered herself with a cotton sheet. Even the ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
16h
Newspoint on MSNWorkplace Dehydration: How It Harms Your Kidneys and Affects Your HealthMany professionals take pride in their busy schedules, often neglecting basic self-care habits like drinking enough water - ...
A VIRAL hack making its rounds on TikTok claims to ‘cure’ painful urinary tract infections. But a doctor has warned that it ...
The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results